Live Breaking News & Updates on Glenn Goddard

Stay updated with breaking news from Glenn goddard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Brokerages Set Intellia Therapeutics, Inc. (NASDAQ:NTLA) Price Target at $75.47

Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Free Report) has earned an average rating of “Moderate Buy” from the eighteen brokerages that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average 12 month price objective […] ....

Johnm Leonard , Glenn Goddard , Raymond James , Intellia Therapeutics Inc , Blue Trust Inc , Group Wealth Management , Jefferies Financial Group Inc , Securities Exchange Commission , China Universal Asset Management Co , Goldman Sachs Group , Intellia Therapeutics , Get Free Report , Exchange Commission , Investment Management , Financial Group , Wealth Management , China Universal Asset Management , Universal Asset Management , Get Free , Intellia Therapeutics Daily , Nasdaq Ntla ,

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Intellia Therapeutics, Inc. (NASDAQ:NTLA – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the nineteen ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendation and fifteen have issued a buy recommendation on […] ....

Robertw Baird , Glenn Goddard , Laura Sepp Lorenzino , Intellia Therapeutics Inc , Securities Exchange Commission , Vanguard Group Inc , Blackrock Inc , Investment Management , Cantor Fitzgerald , Intellia Therapeutics , Get Rating , Chardan Capital , Exchange Commission , State Street Corp , Street Corp , Intellia Therapeutics Daily , Nasdaq Ntla ,